USD10
CRVS Shares
About Corvus PharmaceuticalsCorvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.
USD10
CRVS Shares
About Corvus PharmaceuticalsCorvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.
Stats
TRADING WINDOW
Closed
OPENS AT
Apr 20 at 1:30 PM GMT+0
MARKET CAP
$1.34B
OPEN PRICE
Not enough data
LOW (1Y)
$2.54
HIGH (1Y)
$26.95
LOW (24H)
$16.04
HIGH (24H)
$16.99
VOLUME (24H)
$604.00
99.98%
Price history
Time | Price | Change |
|---|---|---|
Today | Not enough data | Not enough data |
1 Day | $16.99 | |
1 Week | $15.20 | |
1 Month | $13.91 | |
1 Year | $3.22 |
Past performance is not a reliable indicator of future results.
Discover more
Popular stocks
Explore other stocks
Popular prediction markets
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.
